Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Fibril-associated Collagen

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...

Type IV Collagen of Basal Lamina

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can exist in...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Collagens are the Major Structural Proteins of ECM

Collagens are the Major Structural Proteins of ECM

Three main types of fibers are secreted by fibroblasts: collagen fibers, elastic fibers, and reticular fibers. Collagen fiber is made from fibrous protein subunits linked together to form a long, straight fiber. Collagen fibers, while flexible, have great tensile strength, resist stretching, and give ligaments and tendons their characteristic resilience and strength. These fibers hold connective tissues together, even during the body's movement.
Connective tissue proper includes loose...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies.

The British journal of dermatology·2015

Same author

Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica.

Annals of the rheumatic diseases·2012

Same author

Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype.

Arthritis and rheumatism·2011

Same author

Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis.

Arthritis and rheumatism·2010

Same author

NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis.

Annals of the rheumatic diseases·2010

Same author

Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population.

Arthritis and rheumatism·2010

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Quantifying Fibrillar Collagen Organization with Curvelet Transform-Based Tools

Quantifying Fibrillar Collagen Organization with Curvelet Transform-Based Tools

Published on: November 11, 2020

[Genetic analysis in collagen vascular diseases].

¹Klinische Forschergruppe für Rheumatologie, Freiburg, Deutschland. inga.melchers@uniklinik-freiburg.de

Zeitschrift Fur Rheumatologie

|March 23, 2011

Summary

Genetic factors significantly influence collagen vascular diseases, particularly systemic lupus erythematosus (SLE) and systemic scleroderma (SSc). Shared genetic risk factors highlight the close relationship between these autoimmune conditions.

Area of Science:

Immunogenetics
Rheumatology
Molecular Biology

Context:

Collagen vascular diseases, including systemic lupus erythematosus (SLE) and systemic scleroderma (SSc), have known genetic components.
Family studies systematically confirm the importance of genetic factors in SLE and SSc.
A significant overlap exists in validated genetic risk factors for SLE and SSc.

Purpose:

To review and highlight the shared genetic risk factors for systemic lupus erythematosus (SLE) and systemic scleroderma (SSc).
To underscore the relationship between these autoimmune diseases through common genetic underpinnings.
To identify the Human Leukocyte Antigen (HLA) complex as a region of particular interest for genetic risk.

Summary:

Genetic risk factors are integral to all collagen vascular diseases, with notable importance in SLE and SSc.

More Related Videos

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion

Published on: March 18, 2014

Related Experiment Videos

Last Updated: Jun 3, 2026

Quantifying Fibrillar Collagen Organization with Curvelet Transform-Based Tools

Quantifying Fibrillar Collagen Organization with Curvelet Transform-Based Tools

Published on: November 11, 2020

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion

Published on: March 18, 2014

Validated shared risk factors (e.g., PTPN22, STAT4, BANK1, TNFAIP3, IRF5, BLK) reinforce the connection between SLE and SSc.

These identified factors are also associated with other autoimmune disorders, indicating broader genetic influences.

The HLA complex presents a significant area for further investigation due to its polymorphic loci contributing to genetic risk.

Impact:

Provides a consolidated view of key genetic risk factors for SLE and SSc.
Reinforces the genetic basis of autoimmune diseases and their interrelationships.
Highlights the Human Leukocyte Antigen (HLA) complex as a critical area for future research in rheumatology and immunogenetics.